Operation CBDeceit Marks Beginning of FTC Crackdown on Deceptive CBD Medical Claims While FDA Continues to Issue Warning Letters
Seyfarth Attorneys Present to the Association of National Advertisers’ Brand Activation Legal Committee
Not so Pretty: Cosmetic Company Acquisitions Lead to Contentious Trade Secret Spat
Some Things Never Change: COVID-19’s Impact on CBD (or Lack Thereof)
From Brick & Mortar to the Web: An Overview of Federal Laws and Regulations to Consider When Operating an E-Commerce Business
Seyfarth on CBD – February 2020 Update
FDA Stresses CBD Safety Concerns in 15 Warning Letters and Revised Consumer Update
